Core 3: Data Collection & Data Management Core
核心 3:数据收集
基本信息
- 批准号:10263897
- 负责人:
- 金额:$ 429.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgingAlzheimer&aposs DiseaseArchivesCardiacCardiac healthCardiovascular DiseasesCharacteristicsClinicalClinical DataCognitionCognitiveCognitive deficitsCollectionDataData CollectionData SetDementiaDiseaseDoctor of PhilosophyEducational workshopElderlyEnrollmentEnsureEventFollow-Up StudiesGenitourinary systemGoalsHealthHealth behaviorHeart failureHormonesHuman ResourcesImpaired cognitionImpairmentIncentivesIncidenceInfrastructureLaboratoriesLanguageLeadLeadershipLife ExperienceLinkLongevityLongitudinal StudiesLongitudinal cohort studyManuscriptsMeasuresMenopauseMonitorMusculoskeletalParticipantPhysical FunctionPhysiologicalPlayProcessProtocols documentationPublic Health SchoolsQuality ControlQuality of lifeReadingResearchResearch PersonnelResourcesRisk FactorsRoleServicesSex FunctioningSexual HealthSiteSleepSleep disturbancesSpecimenStructureStudy of Women&aposs Health Across the NationSymptomsTechnologyTestingTrainingUniversitiesVaginaVascular DementiaVasomotorVisitVisuospatialWell in selfWomanWomen&aposs HealthWorkactigraphyage relatedbonecardiometabolismcardiovascular healthclinical research sitecognitive functioncognitive performancecohortcritical perioddata centersdata managementdementia riskdesigndisabilityepidemiologic dataexperiencefollow-uphuman old age (65+)improvedinstrumental activity of daily livingmiddle agemild cognitive impairmentmodifiable riskmulti-racialparticipant retentionpre-clinicalpreservationpsychosocialracial and ethnicretention ratesedentary lifestylesocioeconomicssuccess
项目摘要
SWAN-Aging is designed to determine the extent to which midlife health and characteristics of the menopause transition (MT) affect successful aging in women, including the rate of cognitive decline and the risk of dementia and disability. This application proposes to build upon the rich resources of the Study of Women’s Health Across the Nation (SWAN), a longitudinal cohort study initiated in 1994 to characterize the physiological and psychosocial changes that occur during the MT. In SWAN-Aging, we will extend follow-up of the SWAN cohort into early old age (66-75 years) and expand data collection to include additional domains of cognition to detect cognitive impairment (executive and visual-spatial function, language fluency) and the functional impact of cognitive deficits (cognitively demanding instrumental activities of daily living), cardiac health, and sedentary behavior. It is one of a few studies that can quantify the rate of decline in cognitive performance during midlife and early old age and determine the contribution of modifiable risk factors to the incidence of mild cognitive impairment. SWAN-Aging includes three integrated Projects: Project 1 will evaluate the impact of MT characteristics and midlife health indicators on preservation of cognitive function (avoiding cognitive decline and onset of mild cognitive impairment), sleep, genitourinary and sexual function, and quality of life in early old age; Project 2 will test how the MT relates to cardiac health and cardiovascular disease (CVD) events in women in early old age and test how cardiac health relates to early markers of physical impairment, Alzheimer’s disease, and vascular dementia at a critical period in the lifespan; and Project 3 will examine the role of MT and midlife characteristics on musculoskeletal health and physical functioning. The specific aims of Data Collection and Data Management Core (Core 3) are to: 1) Maintain excellent retention of study participants at all clinical sites; 2) Finalize the participant visit protocol and ensure the collection of high quality data from the clinical sites and reading centers; 3) Implement effective quality control measures and provide analytic datasets to study investigators; and 4) Archive and share the SWAN-Aging data. Core 3 will work with the clinical sites to employ effective strategies to maintain SWAN’s high participant retention rate and develop clear, detailed protocols, on-site personnel trainings and quality control measures to monitor the collection of data and specimens. Core 3 will build on the strengths of the existing SWAN data management structure and incorporate improved technology to improve the efficiency of quality control processes. Core 3 will construct datasets to facilitate a variety of analytic strategies to comprehensively assess the role of MT and midlife factors on cognitive decline, cardiac health and physical functioning and will archive de-identified datasets for public use. Core 3 will play a vital role in conducting the Projects by supporting retention and data collection and ensuring that study data will be high quality and used to identify modifiable factors linked to avoidance of mild cognitive impairment, preservation of functioning, and optimization of quality of life in early old age.
SWAN-Aging 旨在确定中年健康和更年期过渡 (MT) 特征对女性成功老龄化的影响程度,包括认知能力下降的速度以及痴呆和残疾的风险。该应用旨在以富人为基础。全国妇女健康研究 (SWAN) 的资源,这是一项于 1994 年启动的纵向队列研究,旨在描述 MT 期间发生的生理和心理变化。在 SWAN-Aging 中,我们将延长 SWAN 队列的随访范围。到早年(66-75岁)并扩大数据收集范围,包括其他认知领域,以检测认知障碍(执行和视觉空间功能、语言流畅性)以及认知缺陷的功能影响(日常生活中认知要求较高的工具性活动) )、心脏健康和久坐行为是少数可以量化中年和老年早期认知能力下降速度并确定可改变的危险因素对轻度认知障碍发生率的研究之一。 SWAN-Aging 包括三个综合项目:项目 1 将评估 MT 特征和中年健康指标对认知功能保存(避免认知能力下降和轻度认知障碍发作)、睡眠、泌尿生殖和性功能以及生活质量的影响。项目 2 将测试 MT 与老年女性的心脏健康和心血管疾病 (CVD) 事件之间的关系,并测试心脏健康与身体损伤、阿尔茨海默病和血管性痴呆的早期标志物之间的关系。生命周期的关键时期;项目 3 将研究 MT 和中年特征对肌肉骨骼健康和身体机能的作用。 数据收集和数据管理核心(核心 3)的具体目标是: 1) 保持研究参与者的良好保留。在所有临床中心; 2) 完成参与者访问协议并确保从临床中心和阅读中心收集高质量的数据; 3) 实施有效的质量控制措施并向研究研究者提供分析数据集;共享 SWAN-Aging 数据,Core 3 将与临床中心合作,采用有效的策略来维持 SWAN 的高参与者保留率,并制定清晰、详细的方案、现场人员培训和质量控制措施来监控数据和样本的收集。 Core 3 将利用现有 SWAN 数据管理结构的优势,并结合改进的技术来提高质量控制流程的效率。 Core 3 将构建数据集以促进各种分析策略,以全面评估 MT 和中年因素的作用。核心 3 将通过支持保留和数据收集并确保研究数据的高质量并用于识别可修改的因素,在项目的实施中发挥至关重要的作用。与避免轻度认知障碍、保留功能和优化老年早期的生活质量有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Mori Brooks其他文献
ORBITA revisited: what it really means and what it does not?
重新审视 ORBITA:它的真正含义是什么,不是什么?
- DOI:
10.1093/eurheartj/ehx796 - 发表时间:
2018 - 期刊:
- 影响因子:39.3
- 作者:
B. Chaitman;Maria Mori Brooks;K. Fox;T. Lüscher - 通讯作者:
T. Lüscher
Maria Mori Brooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Mori Brooks', 18)}}的其他基金
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
- 批准号:
10911525 - 财政年份:2020
- 资助金额:
$ 429.92万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10402934 - 财政年份:2019
- 资助金额:
$ 429.92万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10163253 - 财政年份:2019
- 资助金额:
$ 429.92万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
9926916 - 财政年份:2019
- 资助金额:
$ 429.92万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10642928 - 财政年份:2019
- 资助金额:
$ 429.92万 - 项目类别:
Myocardial Ischemia and Transfusion (MINT) - DCC
心肌缺血和输血 (MINT) - DCC
- 批准号:
10290738 - 财政年份:2016
- 资助金额:
$ 429.92万 - 项目类别:
Treatment and Risk Factor Determinants of Cardiovascular Outcomes in BARI 2D
BARI 2D 心血管结局的治疗和危险因素决定因素
- 批准号:
8625130 - 财政年份:2013
- 资助金额:
$ 429.92万 - 项目类别:
相似国自然基金
阿尔茨海默病高危风险基因加速认知老化的脑神经机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
β-羟丁酸通过hnRNP A1调控Oct4抑制星形胶质细胞衰老影响AD的发生
- 批准号:31900807
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
胰岛素抵抗导致神经元衰老的分子机制及在老年痴呆疾病中的作用研究
- 批准号:91849205
- 批准年份:2018
- 资助金额:200.0 万元
- 项目类别:重大研究计划
慢性睡眠障碍引起阿尔茨海默病tau蛋白病理变化及其表观遗传学机制研究
- 批准号:81771521
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
载脂蛋白E4基因加速认知老化的脑神经机制研究
- 批准号:31700997
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 429.92万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 429.92万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 429.92万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 429.92万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 429.92万 - 项目类别: